STAT3 and colorectal cancer: To evaluate whether targeted gp130/STAT3 inhibition could enhance the cytotoxic effects of chemotherapy treatment, LIM2405 colorectal cancer cells were treated with BZA in combination with standard-of-care chemotherapies, including 5-fluorouracil (5-FU), oxaliplatin and SN38.